# Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section

> **NCT05664659** · PHASE4 · COMPLETED · sponsor: **Ain Shams Maternity Hospital** · enrollment: 90 (actual)

## Conditions studied

- Blood Loss, Surgical
- Intrapartum Hemorrhage

## Interventions

- **DRUG:** Oxytocin + misoprostol
- **DRUG:** Carbetocin

## Key facts

- **NCT ID:** NCT05664659
- **Lead sponsor:** Ain Shams Maternity Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-20
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-05-20
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05664659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05664659, "Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT05664659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*